title: Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease.
authors.affiliation: Department of Neurology.
authors.forename: Eli L
authors.identifier: 0000-0001-5456-5961
authors.initials: EL
authors.lastname: Diamond
authors.affiliation: Leukemia Service, Department of Medicine.|Human Oncology and Pathogenesis Program.
authors.forename: Omar
authors.initials: O
authors.lastname: Abdel-Wahab
authors.affiliation: Human Oncology and Pathogenesis Program.|Department of Pathology, and.
authors.forename: Benjamin H
authors.initials: BH
authors.lastname: Durham
authors.affiliation: Department of Pathology, and.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Dogan
authors.affiliation: Department of Pathology, and.
authors.forename: Neval
authors.initials: N
authors.lastname: Ozkaya
authors.affiliation: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Lynn
authors.initials: L
authors.lastname: Brody
authors.affiliation: Department of Pathology, and.
authors.forename: Maria
authors.initials: M
authors.lastname: Arcila
authors.affiliation: Department of Neurosurgery, University of Utah, Salt Lake City, UT; and.
authors.forename: Christian
authors.initials: C
authors.lastname: Bowers
authors.affiliation: Department of Pediatrics, Hematology-Oncology, University of Utah, Primary Children's Hospital, Salt Lake City, UT.
authors.forename: Mark
authors.initials: M
authors.lastname: Fluchel
mesh_terms: D031249:Erdheim-Chester Disease; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein
chemical_list: D053590:Interleukin 1 Receptor Antagonist Protein